Cover image: Taken from Echegaray JJ, et al, figure 1. Fundus photo of a group C retinoblastoma at presentation, and type 3 regression following episcleral brachytherapy as primary therapy. 7.5 years later, she continues to have 20/20 vision. See page 210.